15
Enhanced Maximal
Pelvic RT plus concurrent low-dose
platinum-based chemotherapy plus
brachytherapy
Adjuvant hysterectomy is an option only
if residual disease aer chemoRT
(EB, H, S)
Pelvic RT plus concurrent low-dose
platinum-based chemotherapy plus
brachytherapy
Adjuvant hysterectomy is an option only if
residual disease aer chemoRT
(EB, H, S)
Pelvic RT plus brachytherapy plus
concurrent low-dose platinum-based
chemotherapy (in some cases extended-
field RT) and/or palliative care
(EB, H, S)
RT + brachytherapy ± concurrent low-
dose platinum-based chemotherapy (may
offer systemic adjuvant chemotherapy)
(EB, I, W)
Pelvic RT plus brachytherapy plus
concurrent low-dose platinum-based
chemotherapy (in some cases extended-
field RT) and/or palliative care (options
before palliative care alone include: RT
boost, salvage surgery, or chemotherapy)
(EB/CB, H, S)
RT + brachytherapy ± concurrent low-
dose platinum-based chemotherapy (may
offer systemic adjuvant chemotherapy)
(EB, I, W)
Chemotherapy ± individualized RT
and/or palliative care
(EB, H, S)
Chemotherapy ± bevacizumab ±
individualized RT and/or palliative care
(EB, H, S)
